Showing 181 - 200 results of 210 for search '"cancer screening"', query time: 0.08s Refine Results
  1. 181

    Interfacial cfDNA Enrichment and Amplification with On‐Chip Thermoplasmonics for Highly Sensitive Cancerous Liquid Biopsy by Danhua Wang, Linlin Liu, Wenjing Chi, Zhenping Liu, Jiayun Wu, Yirou Liang, Fei He, Ruixiang Zhang, Pengxin Huang, Yunbo Li, Guangyu Qiu

    Published 2025-01-01
    “…Through further validation using blood samples from lung cancer patients, the proposed INEAST bioassays demonstrated superior reliability for lung cancer screening, particularly when combined with clinically available tumor‐protein metrics. …”
    Get full text
    Article
  2. 182

    Trends in incidence and mortality of prostate cancer in Ningbo City from 2011 to 2023 by ZHANG Qun,WANG Yong,CHEN Jieping,BAO Kaifang,FENG Yueyi,Wang Xiaoli

    Published 2025-01-01
    “…Special attention should be paid to urban residents, and prostate cancer screening should be strengthened among males aged 50 years and older.…”
    Get full text
    Article
  3. 183

    Diagnostic accuracy of human papillomavirus testing on self-collected samples among women referred for colposcopy by ChunX Yan, Jiong Ma, Xia Zheng, Jing Shu, XiaoJ Wang, XiaoY Chen, Feng Gao, XiaoQ Li, ShanQ M, LongM Huang, XiaoT Yu, XueJ Chen

    Published 2025-01-01
    “…It may be an alternative option for cervical cancer screening. Additional studies are still required to substantiate this issue.…”
    Get full text
    Article
  4. 184

    The Biopsychosocial Burden of Prostate Biopsy at the Time of Its Indication, Procedure, and Pathological Report by Walker W. Laranja, Brunno C. F. Sanches, Brunno R. I. Voris, João C. C. Alonso, Fabiano A. Simões, Ronald F. Rejowski, Leonardo O. Reis

    Published 2019-01-01
    “…To explore the burden of prostate biopsy at the time of its indication, procedure, and pathological report in the prostate cancer-screening scenario that is neglected and underestimated in the literature. …”
    Get full text
    Article
  5. 185

    A systematic review of barriers to early presentation and diagnosis with breast cancer among black women by Ruth H Jack, Jill Maben, Elizabeth A Davies, Emma Ream, Grace Lucas, Claire EL Jones, Lindsay JL Forbes

    Published 2014-02-01
    “…Studies were excluded if they did not report separate findings by ethnic group or gender, only reported differences in time to presentation/diagnosis, or reported on interventions and barriers to cancer screening. We followed Cochrane and PRISMA guidance to identify relevant research. …”
    Get full text
    Article
  6. 186

    Elevated SREBP1 accelerates the initiation and growth of pancreatic cancer by targeting SOX9 by Cancan Zhou, Zhengyuan Feng, Weikun Qian, Zeen Zhu, Ruiqi Cao, Qiqi Wang, Wunai Zhang, Rujuan Liu, Shuai Wu, Jie Hao, Zheng Wang, Qingyong Ma, Zheng Wu, Xuqi Li

    Published 2025-01-01
    “…Taken together, our findings demonstrate that SREBP1/SOX9 inhibition suppresses pancreatic cancer initiation and growth, suggesting that SREBP1 could serve as a potential target for cancer screening and treatment.…”
    Get full text
    Article
  7. 187

    Screening attendance of breast or cervical cancers and its associated factors among 30-49 year old women in Gedeo zone, South Ethiopia: Cross-sectional study. by Abel Desalegn Demeke, Bedilu Deribe, Martha Girma, Muluken Gizaw, Sefonias Getachew, Susanne Unverzagt, Eva J Kantelhardt, Betty Ferrell, Eric Sven Kroeber, Lesley Taylor

    Published 2025-01-01
    “…<h4>Conclusion and recommendation</h4>The study found that only one in four women attended breast or cervical cancer screening. Screening uptake was better in women with higher education, health literacy, self-efficacy, and older age-similar to factors associated with other health seeking behavior. …”
    Get full text
    Article
  8. 188

    Combination Antiretroviral Therapy for HIV in Rwandan Adults: Clinical Outcomes and Impact on Reproductive Health up to 24 Months by Brenda Asiimwe-Kateera, Nienke Veldhuijzen, Jean Paul Balinda, John Rusine, Sally Eagle, Joseph Vyankandondera, Julie Mugabekazi, Pascale Ondoa, Kimberly Boer, Anita Asiimwe, Joep Lange, Peter Reiss, Janneke van de Wijgert

    Published 2015-01-01
    “…We applaud the Rwandan government for having strengthened family planning and PMTCT services and for having introduced HPV vaccination in recent years, but additional work is needed to strengthen STI and HPV-related cancer screening and management in the HIV-positive population.…”
    Get full text
    Article
  9. 189

    Analysis of the predictive value of the prostate-specific antigen-to-neutrophil ratio for the diagnosis of prostate cancer by Yuxuan Chen, Haisheng Yan, Yaoqin Xu, Kexin Chen, Runqin Yang, Jiali Yang, Ruian Zhu, Rui Lin, Jiang Wang, Jie Liu, Pingsheng Gao, Lei Pang, Lexin Wang

    Published 2025-01-01
    “…However, PSA levels in the range of 4–10 ng/ml are considered the ‘grey zone’ of prostate cancer screening. Patients within this range need to be further evaluated using additional parameters such as PSA ratio, PSA density, and other indices to determine the necessity of prostate biopsy (PBx). …”
    Get full text
    Article
  10. 190

    Colorectal Serrated Neoplasia: An Institutional 12-Year Review Highlights the Impact of a Screening Programme by A. J. McCarthy, S. M. O’Reilly, J. Shanley, R. Geraghty, E. J. Ryan, G. Cullen, K. Sheahan

    Published 2019-01-01
    “…Detection of SSL/Ps peaked in the most recent years reviewed (87.5% reported between 2013 and 2016, inclusive), coinciding with the introduction of “BowelScreen” (the Irish FIT-based colorectal cancer screening programme). Conclusions. Awareness of, and adherence to, diagnostic criteria is essential for accurate classification of colorectal polyps.…”
    Get full text
    Article
  11. 191

    Exploring barriers to early breast examination and screening among Arab women in the MENA region: A KAP study by Ehsan Qtaishat, Reem Al-Ajlouni, Khawlah Ammar, Mohammed Liswi, Abdallah Al-Ani, Rasha Fakheraldeen, Shorouq Al-hasson

    Published 2025-02-01
    “…Aim: To examine the knowledge, attitudes, and practices (KAP) regarding early breast cancer screening among women across the MENA region. Methodology: This cross-sectional investigation deployed a survey designed to investigate women's KAP with regards to breast cancer signs and symptoms, early breast cancer detection methods, sources of knowledge, and barriers towards early detection exams. …”
    Get full text
    Article
  12. 192

    Report on the Dutch Consensus Development Meeting for Implementation and Further Development of Population Screening for Colorectal Cancer Based on FOBT by M. de Visser, M. van Ballegooijen, S. M. Bloemers, S. J. H. van Deventer, J. B. M. J. Jansen, J. Jespersen, C. Kluft, G. A. Meijer, J. Stoker, G. A. de Valk, M. F. Verweij, F. A. Vlems

    Published 2005-01-01
    “…Consequently, it was concluded that a national population screening for colorectal cancer should be implemented and carried out in the Netherlands in line with current national and European cancer screening programmes. A list of organisational actions to be taken was established. …”
    Get full text
    Article
  13. 193

    Mammography Among Women Residing in Urban Versus Rural Utah: Breast Cancer Survival by Quinn Tanner, Chun‐Pin Chang, Karen Curtin, James VanDerslice, Lisa Gren, Vikrant Deshmukh, Michael Newman, Ankita Date, Mark Dodson, N. Lynn Henry, Mia Hashibe

    Published 2024-12-01
    “…ABSTRACT Background Annual or biennial breast cancer screenings are recommended for women 40 and older. …”
    Get full text
    Article
  14. 194
  15. 195

    Accuracy of screening tests for cervical precancer in women living with HIV in low-resource settings: a paired prospective study in Lusaka, Zambia by Nicola Low, Partha Basu, Andreas Limacher, Katayoun Taghavi, Misinzo Moono, Mulindi Mwanahamuntu, Herbert Kapesa, Albert Manasyan, Julia Bohlius, Marie Roumet, Thamsanqa Madliwa, Anne Rutjes

    Published 2024-07-01
    “…We assessed the accuracy of screening tests that can be used in low-resource settings and give results at the same visit.Methods and analysis We conducted a paired, prospective study among consecutive eligible WLHIV, aged 18–65 years, receiving cervical cancer screening at one hospital in Lusaka, Zambia. The histopathological reference standard was multiple biopsies taken at two time points. …”
    Get full text
    Article
  16. 196

    Ddx21 mutant peptide is an effective neoantigen in prophylactic lung cancer vaccines and activates long-term anti-tumor immunity by Zhe Zhang, Yimeng Xia, Yimeng Xia, Zhihong Wang, Yaxing Sun, Dan Pu, Yijia He, Ruixian Liu, Yanru Zhang, Yan Liu, Junzhi Yu, Shiyang Ning, Baisui Feng, Yaohe Wang, Na Wang

    Published 2025-02-01
    “…Although low-dose CT lung cancer screening has been shown to reduce lung cancer mortality, its adoption rate is limited and the pace of its promotion is slow, highlighting the urgent need for more effective prevention measures. …”
    Get full text
    Article
  17. 197

    Detection of Cervical Cancer and High Grade Neoplastic Lesions by a Combination of Liquid‐Based Sampling Preparation and DNA Measurements Using Automated Image Cytometry by Xiao Rong Sun, Jian Wang, David Garner, Branko Palcic

    Published 2005-01-01
    “…Objective: To establish if measurements of DNA ploidy could be used to assist cytopathologists and cytotechnologists in population based cervical cancer screening programs in countries where manually reading the slides is impossible due to the lack of sufficient skilled cytotechnologists. …”
    Get full text
    Article
  18. 198
  19. 199
  20. 200

    A gut-derived Streptococcus salivarius produces the novel nisin variant designated nisin G and inhibits Fusobacterium nucleatum in a model of the human distal colon microbiome by Garreth W. Lawrence, Enriqueta Garcia-Gutierrez, A. Kate O’Mahony, Calum J. Walsh, Paula M. O'Connor, Máire Begley, Caitriona M. Guinane, Paul D. Cotter

    Published 2025-02-01
    “…ABSTRACT Fusobacterium nucleatum is a human pathogen associated with intestinal conditions including colorectal cancer. Screening for gut-derived strains that exhibit anti-F. nucleatum activity in vitro revealed Streptococcus salivarius DPC6487 as a strain of interest. …”
    Get full text
    Article